[Supportive day care at a cancer center: A comparative study of 2008 versus 2016 activity].

Hôpital de jour de soins de support dans un Centre de Lutte contre le cancer : étude comparative de l’activité entre 2008 et 2016.
Day care Hôpital de jour Hôpital de jour de soins de support Hôpital de jour de soins palliatifs oncologiques Oncological palliative care Oncological supportive care Oncological supportive day care Soins de support oncologiques Soins palliatifs oncologiques Supportive care Supportive day care

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 02 08 2019
revised: 23 10 2019
accepted: 30 10 2019
pubmed: 2 2 2020
medline: 7 3 2020
entrez: 2 2 2020
Statut: ppublish

Résumé

The Paul Strauss Center day-care accompaniment department ("SSAJ") is an oncologic supportive day-care, also an alternative to conventional hospitalization. In order to follow the SSAJ department's activity, in the "ambulatory turnover" context, we compared the 2008 and 2016 four first months activity. In 2016, there was an average of 4.96 patients per day versus 5.62 in 2008 (P<0.001); average day incoming of 653€ per stay in 2016 versus 775€ in 2008 (P<0.001). In 2016, there was an average 63.9 % of imagery done versus 27.7 % in 2008 (P<0.001). The 2016 average patient following period was of 84.7 days versus 67.6 days in 2008 (P=0.019). Average time between first day-care visit and death was 161.7 days in 2016 versus 133.5 days in 2008 (P=0.0033). Average day activity is lower in 2016 than 2008, nonetheless number of total stays and inpatients has increased on the four months period. The SSAJ intervenes more precociously in 2016 than 2008. Hospital technical platform is better used, but average per-stay incoming has statistically lowered. The SSAJ limits and prepares complete hospitalizations. Inpatient close reevaluation after a "shorter-willing" stay, home issues anticipation and identification with the home-care team, and worsening prevention gives this activity all its meaning.

Identifiants

pubmed: 32005357
pii: S0007-4551(19)30426-6
doi: 10.1016/j.bulcan.2019.10.013
pii:
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Comparative Study Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

181-190

Informations de copyright

Copyright © 2019. Published by Elsevier Masson SAS.

Auteurs

Alexandre Bimboes (A)

Paul-Strauss Cancer Centre, 3, rue de la Porte de l'Hôpital, 67000 Strasbourg, France. Electronic address: ABimboes@strasbourg.unicancer.fr.

Veronique Frasie (V)

Paul-Strauss Cancer Centre, 3, rue de la Porte de l'Hôpital, 67000 Strasbourg, France.

Alicia Thiery (A)

Paul-Strauss Cancer Centre, 3, rue de la Porte de l'Hôpital, 67000 Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH